10-Q Filing

GLOBAL MEDICAL REIT INC. CIK: 1533615 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001078782-14-000721`
Period End Date	20140228
Filing Date	20140422
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	scoo-20140228.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 29 Income Statement 23 Cash Flow Statement 31

Balance Sheet 29 line items

Line Item	Tag	Value	Unit	Period
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash	`Cash`	$3.42K	USD	Point-in-time
Cash	`Cash`	$3.52K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Prepaid expense	`PrepaidExpenseCurrent`	$3.63K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	8.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	8.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.52K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	8.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$7.05K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	8.00M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$19.04K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$20.99K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$23.32K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$380.00	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$19.42K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$44.30K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001, 8,000,000 share issued and outstanding	`CommonStockValue`	$8.00K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001, 8,000,000 share issued and outstanding	`CommonStockValue`	$8.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$72.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$72.00K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-95.91K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-117.26K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$-37.26K	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$-15.90K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$3.52K	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$7.05K	USD	Point-in-time

Income Statement 23 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$3.57K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$117.26K	USD	12 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$31.19K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$21.35K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$13.69K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$31.19K	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$3.57K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$13.69K	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$21.35K	USD	2 Qtrs
Total Operating Expenses	`OperatingExpenses`	$117.26K	USD	12 Qtrs
Net Loss	`ProfitLoss`	$-3.57K	USD	1 Quarter
Net Loss	`ProfitLoss`	$-13.69K	USD	1 Quarter
Net Loss	`ProfitLoss`	$-31.19K	USD	2 Qtrs
Net Loss	`ProfitLoss`	$-117.26K	USD	12 Qtrs
Net Loss	`ProfitLoss`	$-21.35K	USD	2 Qtrs
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.00M	shares	2 Qtrs
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.65M	shares	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.00M	shares	2 Qtrs
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.00M	shares	1 Quarter

Cash Flow Statement 31 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`NetIncomeLoss`	$-21.35K	USD	2 Qtrs
Net loss for the period	`NetIncomeLoss`	$-117.26K	USD	12 Qtrs
Net loss for the period	`NetIncomeLoss`	$-31.19K	USD	2 Qtrs
Prepaid expenses.	`IncreaseDecreaseInPrepaidExpense`	$-3.63K	USD	12 Qtrs
Prepaid expenses.	`IncreaseDecreaseInPrepaidExpense`	$-3.63K	USD	2 Qtrs
Accounts payable - Related party	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$23.32K	USD	2 Qtrs
Accounts payable - Related party	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$23.32K	USD	12 Qtrs
Accrued liabilities.	`IncreaseDecreaseInAccruedLiabilities`	$3.00K	USD	2 Qtrs
Accrued liabilities.	`IncreaseDecreaseInAccruedLiabilities`	$20.61K	USD	12 Qtrs
Accrued liabilities.	`IncreaseDecreaseInAccruedLiabilities`	$1.56K	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-104.00	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-28.19K	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-76.97K	USD	12 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$80.00K	USD	12 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.00K	USD	2 Qtrs
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	$380.00	USD	12 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$25.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$80.38K	USD	12 Qtrs
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.42K	USD	12 Qtrs
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.19K	USD	2 Qtrs
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-104.00	USD	2 Qtrs
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.42K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$9.12K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.52K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash, End of Period	`CashEndOfPeriod`	$3.42K	USD	2 Qtrs
Cash, End of Period	`CashEndOfPeriod`	$9.12K	USD	2 Qtrs
Cash, End of Period	`CashEndOfPeriod`	$3.42K	USD	12 Qtrs
Interest paid	`InterestPaid`	-	USD	12 Qtrs
Income taxes paid	`IncomeTaxesPaid`	-	USD	12 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.